Our results were concordant with the TCGA pan‐cancer pathway analysis that reported 9 and 21% alteration frequencies of the RTK/RAS and p53 pathways in MPM (Sanchez‐Vega et al, 2018). The gene discussed is TP53; the disease is cancer.